We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Pembrolizumab | SpringerLink

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Pembrolizumab

Ascites: case report

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

    This is a preview of subscription content, access via your institution.

    Reference

    1. Schell B, et al. One pill can kill or cure!. Journal of the American Geriatrics Society 68 (Suppl.): S106-S107, Apr 2020. Available from: URL: http://doi.org/10.1111/jgs.16431 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Pembrolizumab. Reactions Weekly 1838, 424 (2021). https://doi.org/10.1007/s40278-021-89741-x

    Download citation